Ledger.
Investor · Senningerberg, Luxembourg

Pierre Weimerskirch

Open Pierre in the network graph →
Filings
12
SEC Form D
Connections
78
co-filers
Capital
$301.9M
across filings
Active
Jan 2014
to Sep 2016

Most-connected co-filers (78)

Geoffrey Limpach · Grand Duchy of Luxembourg, Luxembourg6 sharedAndrea Millioni · Senningerberg, Luxembourg4 sharedRalph Brodel · Senningerberg, Luxembourg4 sharedFlorian Kreitmeier · Munich, 2M4 sharedRonald L. Kirkby · BROOKLYN, NY3 sharedRyan Fliss · Portland, OR3 sharedBernard Pierson · Miami, FL3 sharedJoe H. Urban · Hayward, CA3 sharedHoward Michalski · PORTLAND, OR3 sharedJeffrey L. Hersh · GREENWICH, CT3 sharedAndrew R. Lemmon · Columbus, OH3 sharedMark Friess · Portland, OR3 sharedJonathan Bensamoun · BROOKLYN, NY3 sharedCraig Froude · San Francisco, CA3 sharedMark A. Disanto · Arlington, VA3 sharedRonald E. Shoup · Indianapolis, IN2 sharedSwancap Investment Management S.A · Senningerberg, Luxembourg2 sharedJieh-Shan C. Wang · Rockville, MD2 sharedSwancap Partners Gmbh · Munich, 2M2 sharedStuart Larkins · Chicago, IL2 sharedShaun C. Sparkman · South San Francisco, CA2 sharedCharlie C. Chen · Rockville, MD2 sharedMichael P. Levy · New York, NY2 sharedWolfgang Pfister · Munich, 2M2 shared

Recent filings (12)

MedZero, Inc.Feb 2025 · 5 co-filers$750KApax Global Impact SCSpFeb 2024 · 13 co-filers$8.4MMedZero, Inc.Oct 2022 · 5 co-filers$10.2MApax Global Impact SCSpMar 2022 · 11 co-filersSeLux Diagnostics, Inc.Jun 2021 · 17 co-filers$7.5MMedZero, Inc.Mar 2021 · 5 co-filers$5.7MSeLux Diagnostics, Inc.Oct 2020 · 20 co-filers$1.7MSeLux Diagnostics, Inc.Sep 2019 · 11 co-filers$9.0MPrivate Equity Opportunities Fund III, SCSSep 2016 · 30 co-filers$446.3MAIT Bioscience, LLCJan 2015 · 14 co-filers$1.0MSwanCap Opportunities Fund II SCS - SIFNov 2014 · 27 co-filers$84.9MAIT Bioscience, LLCJan 2014 · 8 co-filers$2.0M

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Pierre in the interactive graph →